Patent Assignment
Reel/Frame 029418/0318
Change of Name
Recorded: 2012-12-06
Pages: 162
Assignor
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Executed: 2011-07-01
Assignee
BAYER PHARMA AKTIENGESELLSCHAFT
MULLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Properties
(3)
Combination Therapy of Substituted Oxazolidinones
Application:
12/513,363 →
Publication:
US 2010/0120718
Oxazolidinones For the Treatment and/or Prophylaxis of Heart Failure
Application:
12/746,661 →
Publication:
US 2011/0003804
Co-Crystal Compound of Rivaroxaban and Malonic Acid
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 24, 2011
From: GRUNENBERG, ALFONS; FAEHNRICH, KARSTEN; QUECKENBERG, OLAF; REUTE, CHRISTIANE
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 025879/0659 →
Assignment of Assignor's Interest
Nov 12, 2012
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029277/0713 →